p53 biology and reactivation for improved therapy in MDS and AML

• المؤلف الرئيسي: Joanna E. Zawacka (مؤلف)
• التنسيق: كتاب
• منشور في: BMC, 2024-03-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Abstract Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) originate from preleukemic hematopoietic conditions, such as clonal hematopoiesis of indeterminate potential (CHIP) or clonal cytopenia of undetermined significance (CCUS) and have variable outcomes despite the successful imple...